Search results
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 15 hours agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according ...
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
FOX 59 Indianapolis· 11 hours agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care Conference ...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 1 day agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings ...
Jazz: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 10 hours agoDUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Wednesday reported a loss of $14.6 million in its first quarter. The Dublin-based company ...
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 8 hours agoThe headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter...
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks via Yahoo Finance· 7 days agoArdelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely...
Psychedelic Drug Market Poised to Hit $4.6B by 2030
High Times· 2 days agoA recent report shows a steady growth in the psychedelic drug market, however the report represents a much more conservative projection compared to past reports, which have blown that projection ...
Breakthrough study on post-traumatic stress disorder
UC Newsroom· 7 days agoThe consortium’s database was assembled from various sources, representing a variety of causes and levels of trauma. Nievergelt said the sources included...
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
FierceBiotech· 2 days agoHarmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more than $600 million in biobucks on the table. The relatively small M ...